- Home
- MSBI vs AUTL Comparison
MSBI vs AUTL Comparison
Compare MSBI & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MSBI | AUTL |
|---|---|---|
| Founded | 1881 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.2M | 431.2M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | MSBI | AUTL |
|---|---|---|
| Price | $21.06 | $1.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $22.83 | $8.50 |
| AVG Volume (30 Days) | 94.7K | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 6.14% | N/A |
| EPS Growth | N/A | ★ 28.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,120,000.00 |
| Revenue This Year | $18.41 | $669.62 |
| Revenue Next Year | $2.07 | $79.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 496.00 |
| 52 Week Low | $14.24 | $1.11 |
| 52 Week High | $24.57 | $2.70 |
Technical Indicators
Market Signals| Indicator | MSBI | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 46.52 |
| Support Level | $20.81 | $1.27 |
| Resistance Level | $22.29 | $1.52 |
| Average True Range (ATR) | 0.62 | 0.09 |
| MACD | -0.15 | -0.02 |
| Stochastic Oscillator | 31.38 | 23.18 |
Price Performance
Historical ComparisonAbout MSBI Midland States Bancorp Inc.
Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment, which generates the majority of the revenue, provides financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage, and other consumer loan products; commercial equipment financing, etc. The Wealth Management segment consists of trust and fiduciary services, brokerage, and retirement planning services. The Corporate segment includes the holding company's financing and investment activities, administrative expenses.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.